Insider Transactions in Q3 2022 at 89bio, Inc. (ETNB)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 30
2022
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
1,297
-1.94%
|
$6,485
$5.79 P/Share
|
Sep 30
2022
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
3,750
+5.32%
|
-
|
Sep 28
2022
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
2,882
-4.38%
|
$14,410
$5.76 P/Share
|
Sep 28
2022
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+11.24%
|
-
|
Sep 28
2022
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,018
-4.55%
|
$10,090
$5.76 P/Share
|
Sep 28
2022
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,833
+11.63%
|
-
|
Sep 28
2022
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,882
-4.38%
|
$14,410
$5.76 P/Share
|
Sep 28
2022
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+11.24%
|
-
|
Sep 28
2022
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,527
-4.99%
|
$57,635
$5.76 P/Share
|
Sep 28
2022
|
Rohan Palekar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,333
+12.61%
|
-
|
Sep 09
2022
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+30.3%
|
-
|
Sep 09
2022
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+28.04%
|
-
|
Sep 09
2022
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+30.3%
|
-
|
Sep 08
2022
|
Rohan Palekar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+33.6%
|
$100,000
$1.93 P/Share
|
Jul 01
2022
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,816,900
+26.58%
|
$8,450,700
$3.55 P/Share
|